Ozdemir, Z. N. Et Al. 2022. Pretransplant Consolidation Therapies Improve the Outcome of Myeloablative Allogeneic Transplantation in Adults with Ph-negative Acute Lymphoblastic Leukemia. Clinical Lymphoma, Myeloma and Leukemia , vol.22, no.8 , 596-600.

Ozdemir, Z. N., Kircali, E., Şahin, U., Seval, G. C., Bozdağ, S. C., Toprak, S. K., ... Yuksel, M. K.(2022). Pretransplant Consolidation Therapies Improve the Outcome of Myeloablative Allogeneic Transplantation in Adults with Ph-negative Acute Lymphoblastic Leukemia. Clinical Lymphoma, Myeloma and Leukemia , vol.22, no.8, 596-600.

Ozdemir, Zehra Et Al. "Pretransplant Consolidation Therapies Improve the Outcome of Myeloablative Allogeneic Transplantation in Adults with Ph-negative Acute Lymphoblastic Leukemia," Clinical Lymphoma, Myeloma and Leukemia , vol.22, no.8, 596-600, 2022

Ozdemir, Zehra N. Et Al. "Pretransplant Consolidation Therapies Improve the Outcome of Myeloablative Allogeneic Transplantation in Adults with Ph-negative Acute Lymphoblastic Leukemia." Clinical Lymphoma, Myeloma and Leukemia , vol.22, no.8, pp.596-600, 2022

Ozdemir, Z. N. Et Al. (2022) . "Pretransplant Consolidation Therapies Improve the Outcome of Myeloablative Allogeneic Transplantation in Adults with Ph-negative Acute Lymphoblastic Leukemia." Clinical Lymphoma, Myeloma and Leukemia , vol.22, no.8, pp.596-600.

@article{article, author={Zehra Narli Ozdemir Et Al. }, title={Pretransplant Consolidation Therapies Improve the Outcome of Myeloablative Allogeneic Transplantation in Adults with Ph-negative Acute Lymphoblastic Leukemia}, journal={Clinical Lymphoma, Myeloma and Leukemia}, year=2022, pages={596-600} }